Shares of Eden Research plc (LON:EDEN – Get Free Report) shot up 2.8% during mid-day trading on Tuesday following insider buying activity. The company traded as high as GBX 4.18 ($0.05) and last traded at GBX 3.70 ($0.05). 12,234,783 shares traded hands during mid-day trading, an increase of 664% from the average session volume of 1,602,016 shares. The stock had previously closed at GBX 3.60 ($0.04).
Specifically, insider Alexander John Abrey bought 540,540 shares of the stock in a transaction on Tuesday, January 28th. The stock was acquired at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($26,902.58).
Eden Research Stock Performance
The firm has a market capitalization of £19.73 million, a P/E ratio of -200.00 and a beta of 0.92. The stock has a fifty day simple moving average of GBX 3.88 and a two-hundred day simple moving average of GBX 4.02. The company has a debt-to-equity ratio of 1.25, a current ratio of 3.80 and a quick ratio of 2.42.
Eden Research Company Profile
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.
Further Reading
- Five stocks we like better than Eden Research
- What is a Secondary Public Offering? What Investors Need to Know
- What Does the Future Hold for Eli Lilly?
- What is the Nikkei 225 index?
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
- What is the Hang Seng index?
- 3 Consumer Stocks Call Option Traders Are Betting Big On
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.